GHAURI PRACTICE — All Prescriptions & Medications — Page 2
Practice Code: F81205 | CANVEY ISLAND, SS8 0EX
Showing results 51-100 of 486
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Esomeprazole | 532 | 24.9K | £1.8K | +31.5% ▲ |
| Mometasone furoate | 526 | 565 | £4.4K | +31.0% ▲ |
| Macrogol 3350 | 522 | 25.9K | £4.4K | -44.3% ▼ |
| Promethazine hydrochloride | 518 | 26.1K | £3.6K | +44.9% ▲ |
| Doxazosin mesilate | 509 | 28.4K | £1.2K | -52.3% ▼ |
| Isosorbide mononitrate | 476 | 19.1K | £2.6K | -28.0% ▼ |
| Bempedoic acid/Ezetimibe | 469 | 19.9K | £37.4K | +668.0% ▲ |
| Dapagliflozin/metformin | 468 | 39.4K | £24.5K | +965.6% ▲ |
| Zopiclone | 461 | 11.2K | £447 | -16.8% ▼ |
| Apixaban | 455 | 30.6K | £2.7K | -65.7% ▼ |
| Tramadol hydrochloride | 440 | 52.0K | £2.1K | -38.6% ▼ |
| Sildenafil (Erectile Dysfunction) | 438 | 3,820 | £523 | -13.1% ▼ |
| 437 | 894 | £31.6K | -19.8% ▼ | |
| Ibuprofen | 434 | 49.9K | £2.6K | -14.7% ▼ |
| Solifenacin | 433 | 18.0K | £764 | -9.3% ▼ |
| Metoclopramide hydrochloride | 430 | 31.8K | £996 | +419.0% ▲ |
| Carbocisteine | 426 | 85.0K | £2.5K | -20.2% ▼ |
| Estradiol with progestogen | 426 | 19.3K | £11.2K | +25.0% ▲ |
| Folic acid | 414 | 14.9K | £331 | -68.1% ▼ |
| Hydrocortisone | 395 | 12.2K | £1.8K | -11.9% ▼ |
| Estradiol | 389 | 22.3K | £4.1K | -52.6% ▼ |
| Flucloxacillin sodium | 384 | 14.1K | £857 | -14.6% ▼ |
| Formoterol/glycopyrronium/budesonide | 379 | 394 | £16.7K | +529.4% ▲ |
| Ezetimibe | 375 | 17.0K | £2.8K | -47.3% ▼ |
| Rivaroxaban | 371 | 18.3K | £11.0K | -39.4% ▼ |
| Budesonide | 370 | 413 | £10.8K | -31.7% ▼ |
| Felodipine | 368 | 16.1K | £2.5K | -38.0% ▼ |
| Losartan potassium | 365 | 15.7K | £705 | -79.4% ▼ |
| Fluticasone furoate/vilanterol | 352 | 424 | £10.2K | +127.4% ▲ |
| Nitrofurantoin | 350 | 5,162 | £2.9K | -26.7% ▼ |
| 349 | 373 | £16.5K | +12.4% ▲ | |
| 339 | 58.0K | £1.5K | -28.6% ▼ | |
| Mebeverine hydrochloride | 321 | 35.4K | £3.0K | +3.4% ▲ |
| Atenolol | 321 | 14.7K | £319 | -46.8% ▼ |
| 319 | 6,050 | £4.4K | -52.0% ▼ | |
| Lamotrigine | 303 | 22.3K | £2.0K | -48.7% ▼ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 296 | 307 | £4.3K | +161.0% ▲ |
| Bendroflumethiazide | 295 | 13.0K | £209 | -61.9% ▼ |
| Spironolactone | 295 | 11.6K | £1.0K | -45.3% ▼ |
| Empagliflozin | 295 | 12.2K | £15.2K | -52.9% ▼ |
| Latanoprost | 290 | 3,978 | £2.1K | -40.3% ▼ |
| Fluticasone/umeclidinium/vilanterol | 286 | 316 | £13.4K | +22.0% ▲ |
| Loperamide hydrochloride | 282 | 25.1K | £531 | +21.1% ▲ |
| Insulin aspart | 281 | 1,842 | £11.6K | -26.2% ▼ |
| Quinine sulfate | 278 | 10.4K | £1.7K | -4.0% ▼ |
| Melatonin | 270 | 16.8K | £2.9K | -18.8% ▼ |
| Hyoscine butylbromide | 262 | 23.7K | £1.6K | +12.4% ▲ |
| 260 | 27.4K | £988 | +98.4% ▲ | |
| Olmesartan medoxomil/amlodipine/hydrochlorothiazide | 255 | 12.3K | £7.1K | +1,512.1% ▲ |
| Naproxen | 254 | 11.0K | £1.5K | -74.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.